Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethics-committee authorization in Germany

H P Graf1, D Cole

  • 1Freiburg Ethics Commission International, Germany.

Journal of Medical Ethics
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.

Molecular genetics and metabolism·2021
Same author

Foods Implicated in U.S. Outbreaks Differ from the Types Most Commonly Consumed.

Journal of food protection·2021
Same author

Rapid response of pityriasis rubra pilaris with psoriasis overlap to secukinumab.

The British journal of dermatology·2019
Same author

Total, methyl and inorganic mercury concentrations in blood and environmental exposure sources in newcomer women in Toronto, Canada.

Environmental research·2018
Same author

Extended International Normalized Ratio testing intervals for warfarin-treated patients.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Poultry: the most common food in outbreaks with known pathogens, United States, 1998-2012.

Epidemiology and infection·2016
Same journal

Suicide is not a public health issue and perhaps very few things should be.

Journal of medical ethics·2026
Same journal

Normalising transparency: an argument for requiring generative AI use declarations in all manuscripts-with a call for commentaries.

Journal of medical ethics·2026
Same journal

Not all personal utilities are equal: a two-tier normative framework for genomic health technology assessment.

Journal of medical ethics·2026
Same journal

Correction: Harms of the current global anti-FGM campaign.

Journal of medical ethics·2026
Same journal

Emergent ethics of xenotransplantation: findings from a survey on public attitudes toward animal to human organ transplantation in the UK.

Journal of medical ethics·2026
Same journal

Is sport in the 'public interest'? Towards a legal and ethical framework for justifying sport-related harm.

Journal of medical ethics·2026
See all related articles

Germany

Area of Science:

  • Medical Law
  • Bioethics
  • Clinical Research Regulation

Background:

  • The German Drug Law (AMG) was revised in 1994, introducing mandatory ethics committee approval for clinical studies.
  • Legislation effective August 17, 1995, requires approval from independent, state-law-administered ethics committees.
  • This revision has created confusion regarding the sanctioning of public and private ethics committees by German states.

Purpose of the Study:

  • To clarify the evolving landscape of ethics committee authorization in Germany.
  • To explain the emergence of both public and private ethics committees.
  • To analyze the legal challenges and implications of ethics committee governance.

Main Methods:

  • Review of the German Drug Law (AMG) revision and its legislative intent.
Keywords:
Biomedical and Behavioral ResearchLegal ApproachWorld Medical Association

Related Experiment Videos

  • Analysis of legal scholarly opinions on ethics committee control and independence.
  • Examination of the conflict between state-administered and medical association-controlled ethics committees.

    • Main Results:

    • The AMG revision empowers German states to establish ethics committees but does not preclude private entities.
    • Exclusive control by medical associations may violate antitrust laws and the independence requirement.
    • The legislature missed an opportunity to clarify the authorization of different ethics committee types.

    Conclusions:

    • The administration of ethics committees by medical associations may conflict with the independence mandate.
    • Uncertainty persists regarding which ethics committee models German states will approve.
    • Clearer legislative guidance is needed to ensure independent ethics review for clinical studies in Germany.